Skip to main content
Premium Trial:

Request an Annual Quote

Ed Chait, Lester Crawford, Steven Galson, Janet Woodcock, Natalie Dakers, Connie Eaves, Thomas Hudson, Kelvin Ogilvie, Jacques Simard, Ronald Worton, CombiMatrix

Premium

People in the News

Ed Chait has been named executive vice president and chief scientific officer at Bioanalytical Systems, the company said last week.

Chait previously served as CEO of Spectral Genomics, and formerly worked for DuPont in marketing and business development. Chait has also served as an advisor to the Purdue Cancer Center since 2002.


US Food and Drug Administration Commissioner Lester Crawford has appointed Steven Galson to be director of the FDA's Center for Drug Evaluation and Research, the agency said in a statement last week.

Galson, a rear admiral in the commissioned corps of the US Public Health Service, had most recently served as acting center director, and formerly served as deputy director since he joined the FDA in 2001. Galson holds a BS from Stony Brook University, an MD from the Mt. Sinai School of Medicine, and an MPH from the Harvard School of Public Health.

Galson replaces Janet Woodcock as director of the CDER. Woodcock has been named deputy commissioner for operations and chief operating officer at the FDA, Crawford said.


As of last week, Genome Canada's board includes Natalie Dakers, the CEO of British Columbia's Centre for Drug Research and Development; Connie Eaves a professor of medicine at the University of British Columbia; Thomas Hudson, the director of the McGill University and Genome Quebec Innovation Centre and a past assistant-director of the Whitehead Institute/MIT Center for Genome Research; Kelvin Ogilvie, a professor of chemistry at Acadia University in Nova Scotia; Jacques Simard, the director of the Cancer Genomics Laboratory at Centre Hospitalier Universitaire de Québec; and Ronald Worton, the CEO and scientific director for the Ottawa Health Research Institute.

 

New Products

CombiMatrix this week launched its CustomArray DNA Synthesizer, which the company said will enable researchers to build microarrays in their own facilities. According to a statement from the Mulkiteo, Wash.-based array company, the platform consists of the DNA CustomArray Synthesizer instrument and its CustomArrays. The instrument has been configured to make CombiMatrix's CustomArray 12K, a semiconductor-based array with 12,000 sites integrated onto a standard 1" x 3" slide format.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.